Treatment of rosacea: topical clindamycin versus oral tetracycline

Int J Dermatol. 1993 Jan;32(1):65-7. doi: 10.1111/j.1365-4362.1993.tb00974.x.

Abstract

Background: A new topical antibiotic preparation, clindamycin in a lotion base, was compared with oral tetracycline in the treatment of rosacea. Forty-three patients clinically diagnosed as having rosacea were examined in an investigator-blinded study.

Methods: Patients used topical clindamycin lotion applied twice daily or the usual oral dose of tetracycline hydrochloride (250 mg four times a day for 3 weeks, then 250 mg twice a day for the remaining 9 weeks). Patients' lesions were examined clinically at 3-week intervals over a period of 12 weeks.

Results: Topical clindamycin treatment produced similar clinical results to oral tetracycline and was superior in the eradication of pustules.

Conclusions: These results show topical clindamycin in a lotion base to be a safe and effective alternative to oral tetracycline therapy in the treatment of rosacea.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Cutaneous
  • Administration, Oral
  • Adult
  • Aged
  • Clindamycin / analogs & derivatives*
  • Clindamycin / therapeutic use
  • Double-Blind Method
  • Follow-Up Studies
  • Humans
  • Middle Aged
  • Rosacea / drug therapy*
  • Tetracycline / therapeutic use*

Substances

  • Clindamycin
  • clindamycin phosphate
  • Tetracycline